Bivalirudin patient counseling information: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Bivalirudin}} {{CMG}} {{AE}}{{JH}} ==Title== <ref>{{Cite web | last = | first = | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIO...")
 
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}}{{JH}}
{{CMG}} {{AE}}{{JH}}


==Title==
==Patient Counseling Information==


Advise patients to watch carefully for any signs of bleeding or bruising and to report these to their health care provider when they occur.


Advise patients to discuss with their health care provider their use of any other medications, including over-the-counter medications or herbal products, prior to Angiomax use. Examples of other medications that should not be taken with Angiomax are warfarin and heparin.


<ref>{{Cite web  | last =  | first =  | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=911cd48f-01ea-4dec-b30c-95e7e0ea9d2a | publisher =  | date =  | accessdate = 10 March 2014 }}</ref>
Marketed by:
The Medicines Company
Parsippany, NJ 07054
For information call: (800) 264-4662
 
U.S. Patents 5,196,404; 7,598,343; 7,582,727
 
Hemochron® is a registered trademark of International Technidyne Corporation, Edison, NJ.<ref>{{Cite web  | last =  | first =  | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=911cd48f-01ea-4dec-b30c-95e7e0ea9d2a | publisher =  | date =  | accessdate = 10 March 2014 }}</ref>


==References==
==References==

Revision as of 18:34, 10 March 2014

Bivalirudin
ANGIOMAX® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Bivalirudin
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

Patient Counseling Information

Advise patients to watch carefully for any signs of bleeding or bruising and to report these to their health care provider when they occur.

Advise patients to discuss with their health care provider their use of any other medications, including over-the-counter medications or herbal products, prior to Angiomax use. Examples of other medications that should not be taken with Angiomax are warfarin and heparin.

Marketed by: The Medicines Company Parsippany, NJ 07054 For information call: (800) 264-4662

U.S. Patents 5,196,404; 7,598,343; 7,582,727

Hemochron® is a registered trademark of International Technidyne Corporation, Edison, NJ.[1]

References

  1. "ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY]". Retrieved 10 March 2014.

Adapted from the FDA Package Insert.